Article | August 10, 2022

Ophthalmic Formulation Development: Inside Ophthalmic Preparation

Source: Ascendia Pharma

Ophthalmic formulation development is receiving more attention in the pharmaceutical industry as of late thanks to advances in technology, increasing awareness of eye diseases, and an aging population. As people live longer, the need to find innovations in treating cataracts, macular degeneration, glaucoma, and diabetic retinopathy grows. 

As pharmaceutical companies anticipate continued growth in this market, the demand for contract development and manufacturing organizations (CDMOs) with experience in the formulation of ophthalmic products is on the rise.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader